Ticker brief
MDCX
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
6
authors 14d
5
crowd 14d
-2.7σ
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-10-05 → 2026-10-12 · now -0.10 (−1 bearish … +1 bullish)
Who spoke5
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @proactive_x | C | -1.13 | 2 | +0.25 |
| @CrweWorld | C | · | 1 | +0.10 |
| @Optimalinvestme | C | -2.28 | 1 | -0.20 |
| @abc51648039 | C | -0.96 | 1 | +0.00 |
| @dmdt14 | C | -0.48 | 1 | -0.20 |
Recent signals6of 6 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-12 | @dmdt14 | -0.20 | Lists six reverse splits effective today with explicit consolidation ratios. | · | tweet ↗ |
| 2026-10-12 | @abc51648039 | +0.00 | Reverse-split watchlist gives split ratios and post-split floats while disclaiming an upside signal. | · | tweet ↗ |
| 2026-10-11 | @Optimalinvestme | -0.20 | Reports that five named stocks will execute reverse splits tomorrow. | · | tweet ↗ |
| 2026-10-08 | @proactive_x | +0.25 | Medicus Pharma targets partnerships and clinical milestones as its oncology pipeline advances. | · | tweet ↗ |
| 2026-10-08 | @CrweWorld | +0.10 | Relays a company progress update framed around a potential path to long-term value. | · | tweet ↗ |
| 2026-10-05 | @proactive_x | +0.25 | Medicus seeks FDA alignment for a streamlined Phase 2b/3 study. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.